News & Events Poster: ESMO Congress 2022BiomeDx presents multi-centric validation of BiomeOne® at the ESMO Congress 2022 VIENNA, September 19th: The…Catia PacificoSeptember 19, 2022
News & Events Poster: 55th Austrian Society for Gastroenterology and Hepatology (ÖGGH) 2022BiomeDx presents newest findings on microbiome signatures predicting colorectal cancer and adenoma. VIENNA, September 8th:…Nikolaus GascheSeptember 9, 2022
Publications & Posters ÖGGH 2022: Analysis of colorectal cancer and adenoma microbiome signatures and the application of machine learning classification as a potential screening toolNikolaus GascheSeptember 9, 2022
Publications & Posters Distance-based Techniques for Personal Microbiome IdentificationNikolaus GascheSeptember 7, 2022
Publications & Posters Utility and Privacy Assessment of Synthetic Microbiome DataNikolaus GascheSeptember 7, 2022
News & Events ML4Microbiome in Turku14th Management Committee Meeting & Working Groups Meeting VIENNA, August 31st: The 4th meeting of…Catia PacificoAugust 31, 2022
Publications & Posters WCLC 2022: Introducing “BiomeOne”, a microbiome-based biomarker to predict immune checkpoint inhibitor response in NSCLC patientsNikolaus GascheAugust 16, 2022
Publications & Posters Shift of dietary carbohydrate source from milk to various solid feeds reshapes the rumen and fecal microbiome in calvesCatia PacificoJuly 20, 2022
Press Releases Intestinal microbiome as cancer hope: new predictive test makes life easier for patientsVIENNA, July 2022: Vienna-based Biome Diagnostics launches the first and only gut microbiome-based predictive test…Nikolaus GascheJuly 18, 2022
News & Events Biome Diagnostics wins EY ScaleUp Award BioTech & HealthcareVIENNA, June 2022 Exciting times for Biome Diagnostics! The company has been awarded with the…Barbara SladekJune 12, 2022